Method of treating cerebral ischemia

Details Method of treating cerebral ischemia Method of treating cerebral ischemia

1985-05-20

1987-08-04

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 14, 514809, A61K 3702

Patent

active

046846247

ABSTRACT:
A method of treatment for patients suffering from cerebral ischemia is provided by administering an opioid peptide. Particulary preferred is the administration of dynorphin, or dynorphin-related peptides, in the acid or amidated form. Practice of the invention is useful in prolonging survival.

REFERENCES:
patent: 2149007 (1979-04-01), Buckler et al.
patent: 3952006 (1976-04-01), Tahara et al.
patent: 3985758 (1976-10-01), Murakami et al.
patent: 4256883 (1981-03-01), Nicolaou et al.
patent: 4267182 (1981-05-01), Holaday et al.
patent: 4280494 (1981-07-01), Cosgrove, Jr. et al.
patent: 4351337 (1982-09-01), Sidman
patent: 4361553 (1982-11-01), Loh et al.
patent: 4364951 (1982-12-01), Skuballa et al.
patent: 4394385 (1983-07-01), Cragoe
patent: 4399129 (1983-08-01), Gowers et al.
patent: 4464358 (1984-08-01), Cox
Kiang et al., Exp. Ther. (1983), "Tolerance to Morphine Bradycardia in the Rat".
Wei et al., Life Sciences, vol. 26, pp. 1517-1522, (1980), "Cardiovascular Effects of Peptides Related to the Enkephalins and Casomorphin".
Kiang et al., Amer. Soc. Phar. Exp. Thera., 1982 FASEB Abstract Form, "Tolerance Development to Morphine Bradycardia in the Rat and Its Modification by Dynorphin (1-13) and Leucine-Enkephalin".
Sapru et al., Jour. Phar. & Exp. Ther. 217:228-234 (1981), "Stimulation of Pulmonary J Receptors by an Enkephalin-Analog".
Baskin & Hosobuchi, "Naloxone Reversal of Ischaemic Neurological Deficits in Man," Lancet 2:272-275 (1981).
Hosobuchi et al., "Reversal of Induced Ischemic Neurologic Deficit in Gerbils by the Opiate Antagonist Naloxone," Science, 215:69-71 (1982).
Levy et al., "Failure of Naloxone to Limit Clinical or Morphological Brain Damage in Gerbils with Unilateral Carotid Artery Occlusion," Abstracts of the 12th Annual Meeting of the Society for Neuroscience, p. 248 (1982).
Holaday & D'Amato, "Naloxone or TRH Fails to Improve Neurologic Deficits in Gerbil Models of `Stroke`", Life Science, 31:385-392, (1982).
Imura et al., Ann. Rev. Physiol. 43:265-278 (1981).
Viveros et al., Adv. Biochem. Psychopharmacol, 221 191-204 (1980).
Lang et al., Life Sci., 32:399-406 (1983).
Elde et al., Neuroscience 1:349-357 (1976).
Polak et al., Lancet 1:972-974 (1977).
Alumets et al., Histochem 56: 187-196 (1978).
Woo et al., Life Sciences 31:1817-1882 (1982).
O'Brien & Waltz, "Transorbital Approach for Occluding the Middle Cerebral Artery Without Craniectomy," Stroke 4: 201-206 (1973).
Science, vol. 218, pp. 592-593. Nov. 5, 1982, "Naloxone and Ischemic Neurologic Deficits in the Gerbil: Is There an Effect?", Holaday & D'Amato.
Science, vol. 218, p. 594, Commentary on Letter, Hosobuchi & Baskin.
Chem Abstracts Citation of Hosobuchi et al., vol. 97, 174869h in Adv. Endog. Exog. Opioids, Proc. Int. Narc. Res. Conf. 12th (1982).
Nature, vol. 312, Dec. 6, 1984, "Dynorphin(1-13) Improves Survival in Cats with Focal Cerebral Ischaemia", Baskin et al.
Life Sciences, vol. 31, pp. 2201-2204, (1982), "Naloxone Reversal of Ischemic Neurologic Deficits in Baboons is not Mediated by Systemic Effects", Baskin et al.
Life Sciences, vol. 31, pp. 2205-2208, "Effect of Naloxone on Neurologic Deficit & Cortical Blood Flow During Focal Cerebral Ischemia in Cats", Levy et al. (1982).

Affiliated with

Also associated with

Rating

Method of treating cerebral ischemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating cerebral ischemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cerebral ischemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-883858